Search Results
May 05, 2026, 18:16 ET Multi-Stakeholder Expert Panel Finds UTI Management in the United States Represents a Solvable Systemic Failure Costing More Than $6 Billion Annually
Microbiol. Infect. Dis. 2023, 107, 116015, doi:10.1016/j.diagmicrobio.2023.116015.6 Hansen, M.A.; Valentine-King, M.; Zoorob, R.; Schlueter, M.; Matas, J.L.; Willis, S.E.; Danek, L.C.K.; Muldrew, K.L.; Zare, M.; Hudson, F.; et al. Prevalence and Predictors of Urine Culture Contamination
More news about: Pathnostics
May 05, 2026, 17:59 ET /C O R R E C T I O N -- ACTIVE MINDS, INC./
reflecting a broader push to make mental health support as visible and accessible as physical health resources. Led by Reps. Houchin (R-IN), Trahan (D-MA), Valadao (R-CA), and Pocan (D-WI), the bipartisan bill advances two core priorities: expanding access to mental health crisis resources by including
More news about: ACTIVE MINDS, INC.
May 05, 2026, 17:35 ET PIRELLI WILL START CYBER™ TYRE PRODUCTION IN GEORGIA UNDERLINING THE STRATEGIC IMPORTANCE OF THE U.S. MARKET
strategic markets.The Rome, Georgia, plant specializes in high-value tire production for the North American market. It also hosts a dedicated R&D center, further strengthening its role in technological development and product innovation.The facility is recognized for its responsible sourcing
More news about: Pirelli North America
May 05, 2026, 16:58 ET The Chemours Company Reports First Quarter Results
Freon™ sales and a transition to a more favorable product mix in Opteon™ Refrigerant blends, partially offset by higher input costs associated with R32, a key component of our stationary Opteon™ Refrigerant blends, in the quarter.Sequentially, Net Sales increased 28%, driven by a 22% seasonal
More news about: The Chemours Company
May 05, 2026, 16:05 ET Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results
incurred in 1Q25, partially offset by higher compensation-related expenses in 1Q26 including costs relating to Modeyso.Research and development (R&D) expenses, on a GAAP and non-GAAP adjusted basis, increased in 1Q26, primarily due to the addition of costs relating to Modeyso including personnel
More news about: Jazz Pharmaceuticals plc
May 05, 2026, 16:05 ET Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results
incurred in 1Q25, partially offset by higher compensation-related expenses in 1Q26 including costs relating to Modeyso.Research and development (R&D) expenses, on a GAAP and non-GAAP adjusted basis, increased in 1Q26, primarily due to the addition of costs relating to Modeyso including personnel
More news about: Jazz Pharmaceuticals plc
May 05, 2026, 16:05 ET The Andersons, Inc. Reports First Quarter Results
https://app.webinar.net/r9QEJNbJ2Mk and submit the requested information as directed. A replay of the call can also be accessed under the heading "Investors" on the
More news about: The Andersons, Inc.
May 05, 2026, 16:05 ET Solventum Reports First Quarter 2026 Financial Results
seasonality.Other Business and Operational HighlightsCelebrated the grand opening of a new 250,000 square foot flagship R&D center of excellence in Eagan, Minnesota, featuring modern workspaces, a pilot factory and a dedicated quality lab to fuel a steady pipeline of healthcare
More news about: Solventum
May 05, 2026, 16:01 ET Rigel Reports First Quarter 2026 Financial Results
safety, tolerability, pharmacokinetics, and preliminary efficacy of R2891, a potent and selective dual inhibitor of interleukin receptor-associated kinases 1 and 4 (IRAK1/4), in patients with relapsed or refractory (R/R) lower-risk myelodysplastic syndrome (MDS). Enrollment in the dose expansion
More news about: Rigel Pharmaceuticals, Inc.
May 05, 2026, 16:01 ET Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
candidates. Development milestones are included in R&D guidance once achieved or deemed probable to achieve.Non-GAAP guidance adjusted to exclude estimated non-cash stock-based compensation expense of approximately $90 million in R&D and $125 million in SG&A, divestiture-related expenses
More news about: Neurocrine Biosciences, Inc.
May 05, 2026, 15:40 ET ImmunityBio, Inc. (IBRX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to ImmunityBio, Inc. ("ImmunityBio" or the "Company") (NASDAQ:
More news about: The Law Offices of Frank R. Cruz, Los Angeles
May 05, 2026, 15:37 ET ChowChow Cloud International Holdings Limited (CHOW) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to ChowChow Cloud International Holdings Limited ("CHOW" or the "Company") (NYSE American:
More news about: The Law Offices of Frank R. Cruz, Los Angeles
May 05, 2026, 15:35 ET Gemini Space Station, Inc. (GEMI) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Gemini Space Station, Inc. ("Gemini" or the "Company") (NASDAQ:
More news about: The Law Offices of Frank R. Cruz, Los Angeles
May 05, 2026, 15:33 ET Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ:
More news about: The Law Offices of Frank R. Cruz, Los Angeles
May 05, 2026, 13:48 ET The Board of Directors of UPM-Kymmene Corporation has approved a demerger plan concerning the separation of the Plywood business into a new listed company
https://news.cision.com/upm-kymmene-oyj/r/the-board-of-directors-of-upm-kymmene-corporation-has-approved-a-demerger-plan-concerning-the-separa,c4342094The following files are available for download:
More news about: UPM-Kymmene Oyj
May 05, 2026, 13:45 ET Hyundai Sponsors BeachLife Festival and Donates $15,000 to Adopt the Arts Foundation
headquarters in California, the Hyundai Motor Manufacturing Alabama assembly plant, the all-new Hyundai Motor Group Metaplant America, several cutting-edge R&D facilities and more than 855 independent dealers. These operations are part of Hyundai Motor Group, which is
More news about: Hyundai Motor America
May 05, 2026, 13:30 ET Xtalks Launches Pharmaville Smart Locator to Support Global Life Science Location Discovery
The new Pharmaville Smart Locator supports early-stage location discovery and ecosystem research across pharma, biotech, medtech, R&D, clinical research and manufacturing. It helps life science professionals, companies and regions better understand where industry activity is concentrated and
More news about: Xtalks
May 05, 2026, 13:25 ET /C O R R E C T I O N -- North Carolina Community College System/
More news about: North Carolina Community College System
May 05, 2026, 12:52 ET Report from the Annual General Meeting of Vitrolife AB (publ)
https://news.cision.com/vitrolife-ab--publ-/r/report-from-the-annual-general-meeting-of-vitrolife-ab--publ-,c4344174
More news about: Vitrolife AB (publ)
May 05, 2026, 12:22 ET Compass Global Communications Welcomes 20-year Communications Expert Jeff Leieritz as Senior Director of Strategic Communications
media relations and coalition development for the U.S. House of Representatives' Committee on Small Business under former Chairman Rep. Sam Graves (R-Mo.)."We are thrilled to welcome Jeff to the Compass Global family. Jeff is a rare talent who has a deep understanding of the nexus between communications
More news about: Compass Global Communications
